Form 4: Agilon Health CFO's Stock Withholding for Tax Obligations Detailed in Latest SEC Filing

Agilon Health's Chief Financial Officer, Jeffrey A. Schwaneke, reported the withholding of 9,331 shares of common stock by the issuer to cover tax obligations related to restricted stock units.

Summary

• Jeffrey A. Schwaneke, Chief Financial Officer of agilon health, inc. (AGL), filed a Form 4 detailing a transaction on May 28, 2025.
• The transaction involved the disposition of 9,331 shares of Common Stock by the issuer.
• These shares were withheld by agilon health, inc. to satisfy income tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
• The transaction was not a discretionary sale by Mr. Schwaneke.
• The shares were valued at $2.35 per share for the purpose of this withholding.
• Following this transaction, Mr. Schwaneke beneficially owns 1,121,221 shares of Common Stock, which includes restricted stock units.

Sentiment

Score: 5

Explanation: The transaction is a routine tax withholding related to the vesting of restricted stock units, which is a non-discretionary event and does not reflect a discretionary sale or purchase by the insider, thus indicating a neutral sentiment.

Positives

• The transaction indicates the vesting of restricted stock units, a routine component of executive compensation, which can be viewed positively for executive retention and alignment of interests.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: This filing provides transparency regarding executive compensation and stock ownership, indicating the routine vesting of restricted stock units for a key executive.

Key Dates

Keywords

agilon health, AGL, Form 4, SEC filing, insider transaction, stock withholding, restricted stock units, executive compensation, Jeffrey A. Schwaneke